BMS 223131
Latest Information Update: 20 Mar 2007
At a glance
- Originator Bristol-Myers Squibb
- Class Erectile dysfunction therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 20 Mar 2007 Discontinued - Clinical-Phase-Unknown for Erectile dysfunction in USA (PO)
- 07 Aug 2001 New profile
- 07 Aug 2001 Investigation in Erectile dysfunction in USA (PO)